Micelles of methoxy poly(ethylene glycol)-poly(ε-caprolactone) as a novel drug delivery vehicle for tacrolimus

Journal of Biomedical Nanotechnology

Volumn 9, Issue 2, 2013, Pages 147-157

  Wang, Yingjing ^a   Wang, Cheng ^a   Wang, Yujun ^a   Luo, Feng ^a   Yan, Xi ^a   Qian, Zhiyong ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

MPEG PCL; Polymeric Micelles; Sustained Release; Tacrolimus; Ulcerative Colitis

Indexed keywords

MPEG-PCL; POLYMERIC MICELLE; SUSTAINED RELEASE; TACROLIMUS; ULCERATIVE COLITIS;

COPOLYMERS; DISEASES; DRUG DELIVERY; DRUG PRODUCTS; HYDROPHOBICITY; LOW TEMPERATURE DRYING; POLYETHYLENE GLYCOLS; TRANSMISSION ELECTRON MICROSCOPY;

MICELLES;

COPOLYMER; METHOXY POLY(ETHYLENE GLYCOL) POLY(EPSILON CAPROLACTONE); TACROLIMUS; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COLITIS; DIFFERENTIAL SCANNING CALORIMETRY; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG SYNTHESIS; FREEZE DRYING; HYDROPHOBICITY; IN VITRO STUDY; MALE; MICELLE; MOUSE; NONHUMAN; PARTICLE SIZE; TRANSMISSION ELECTRON MICROSCOPY; X RAY DIFFRACTION;

ANIMALS; BODY WEIGHT; CALORIMETRY, DIFFERENTIAL SCANNING; COLON; DRUG DELIVERY SYSTEMS; HEMOLYSIS; MALE; MICE; MICE, INBRED BALB C; MICELLES; MICROSCOPY, ELECTRON, TRANSMISSION; PARTICLE SIZE; POLYESTERS; POLYETHYLENE GLYCOLS; RABBITS; TACROLIMUS; TEMPERATURE; X-RAY DIFFRACTION;

EID: 84876583557     PISSN: 15507033     EISSN: 15507041     Source Type: Journal    
DOI: 10.1166/jbn.2013.1489     Document Type: Article

References (54)

1. A. W. Thomson, FK506 enters the clinic. Immunol. Today 11, 35 (1990).
2. T. Assmann, B. Homey, and T. Ruzicka, Applications of tacrolimus for the treatment of skin disorders. Immunopharm. 47, 203 (2000).
3. K. A. Jørgensen, P. B. Koefoed, and N. Karamperis, Calcineurin, phosphatase activity and immunosuppression, a review on the role of calcineurin phosphatase activity and the immunosuppressive effect of cyclosporin A and tacrolimus. Scand. J. Immunol. 57, 93 (2003).
4. A. K. Gupta, A. Adamiak, and M. Chow, Tacrolimus: A review of its use for the management of dermatoses. J. Eur. Acad. Dermatol. Venereol. 16, 100 (2002).
5. J. J. Fung, Tacrolimus and transplantation: A decade in review. Transplantation 77, 41 (2004).
6. Prograf [package insert], Deerfield, Fujisawa Healthcare Inc., IL (2003).
7. K. Fellermann, Z. Tanko, K. R. Herrlinger, T. Witthoeft, N. Homann, A. Bruening, D. Ludwig, and E. F. Stange, Response of refractory colitis to intravenous or oral tacrolimus (FK506). Inflamm. Bowel. Dis. 8, 317 (2002).
8. D. C. Baumgart, B. Wiedenmann, and A. U. Dignass, Successful therapy of refractory pyoderma gangrenosum and periorbital phlegmona with tacrolimus (FK506) in ulcerative colitis. Inflamm. Bowel. Dis. 10, 421 (2004).
9. K. Fellermann, D. Ludwig, M. Stahl, T. David-Walek, and E. F. Stange, Steroid-unresponsive acute attacks of inflammatory bowel disease: Immunomodulation by tacrolimus (FK506). Am. J. Gastroenterol 93, 1860 (1998).
10. N. Matsuhashi, A. Nakajima, K. Watanabe, Y. Komeno, A. Suzuki, S. Ohnishi, M. Omata, K. Kondo, Y. Usui, J. I. Iwadare, T. Watanabe, H. Nagawa, and T. Muto, Tacrolimus in corticoid-resistant ulcerative colitis. J. Gastroenterol. 35, 655 (2000).
11. S. Aiko, E. M. Conner, J. A. Fuseler, and M. B. Grisham, Effects of cyclosporine or FK506 in chronic colitis. J. Pharmacol. Exp. Ther. 280, 1075 (1997).
12. A. Higa, G. W. McKnight, and J. L. Wallace, Attenuation of epithelial injury in acute experimental colitis by immunomodulators. Eur. J. Pharmacol. 239, 171 (1993).
13. H. Hoshino, H. Goto, S. Sugiyama, T. Hayakawa, and T. Ozawa, Effects of FK506 on an experimental model of colitis in rats. Aliment. Pharm. Ther. 9, 301 (1995).
14. D. C. Baumgart and B. Wiedenmann, Rescue therapy with tacrolimus is effective in patients with severe and refractory inflammatory bowel disease. Aliment. Pharm. Ther. 17, 1273 (2003).
15. C. Högenauer, H. H. Wenzl, T. A. Hinterleitner, and W. Petritsch, Effect of oral tacrolimus (FK506) on steroid-refractory moderate/ severe ulcerative colitis. Aliment. Pharm. Ther. 18, 415 (2003).
16. Inc., A. P. Approval of Additional Indications for the Immunosuppressant Prograf® for Ulcerative Colitis in Japan (2009).
17. K. A. Head and J. S. Jurenka, Inflammatory bowel disease part I: Ulcerative colitis-pathophysiology and conventional and alternative treatment options. Altern. Med. Rev. 8, 247 (2003).
18. T. T. Macdonald and S. H. Murch, Aetiology and pathogenesis of chronic inflammatory bowel disease. Bailliére's Clinical Gastroenterology 8, 1 (1994).
19. R. Goyal, S. K. Tripathi, S. Tyagi, K. Ravi Ram, K. M. Ansari, P. Kumar, Y. Shukla, D. Kar Chowdhuri, and K. C. Gupta, Gellan gum-PEI nanocomposites as efficient gene delivery agents. J. Biomed. Nanotechnol. 7, 38 (2011).
20. T. T. Liu, X. Y. L, B. Kan, Q. F. Guo, X. H. Wang, S. Shi, G. Guo, F. Luo, X. Zhao, Y. Q. Wei, and Z. Y. Qian, Enhanced gene delivery using biodegradable poly(ester amine)s (PEAs) based on low-molecular-weight polyethylenimine and poly(-caprolactone)-pluronic-poly(-caprolactone). J. Biomed. Nanotechnol. 6, 351 (2010).
21. A. K. Verma, R. P. Pandey, A. Chanchal, and P. Sharma, Immunopotentiating role of encapsulated proteins of infectious diseases in biopolymeric nanoparticles as a potential delivery system. J. Biomed. Nanotechnol. 7, 63 (2011).
22. L. Jorgensen, S. M., and M. van de Weert, Analysis of protein physical stability in lipid based delivery systems - The challenges of lipid drug delivery systems. J. Biomed. Nanotechnol. 5, 401 (2009).
23. S. Rai, R. Paliwal, and S. P. Vyas, Doxorubicin encapsulated nanocarriers for targeted delivery to estrogen responsive breast cancer. J. Biomed. Nanotechnol. 7, 121 (2011).
24. R. Paliwal, S. Rai, and S. P. Vyas, Lipid drug conjugate (LDC) nanoparticles as autolymphotrophs for oral delivery of methotrexate. J. Biomed. Nanotechnol. 7, 130 (2011).
25. D. Liu, L. Wang, Z. Liu, C. Zhang, and N. Zhang, Preparation, characterization, and in vitro evaluation of docetaxel-loaded poly(lactic acid)-poly(ethylene glycol) nanoparticles for parenteral drug delivery. J. Biomed. Nanotechnol. 6, 675 (2010).
26. D. D. Lasic, Liposomes: From Physics to Applications, Elsevier, Amsterdam and New York (1993).
27. D. K. Smith and F. Diederich, Supramolecular dendrimer chemistry: A journey through the branched architecture. Top. Curr. Chem. 210, 183 (2000).
28. A. W. Bosman, H. M. Janssen, and E. W. Meijer, About dendrimers: Structure, physical properties, and applications. Chem. Rev. 99, 1665 (1999).
29. J. M. J. Fréchet, Dendrimers and supramolecular chemistry. P. Natl. Acad. Sci. USA 99, 4782 (2002).
30. K. K. Bansal, D. Kakde, U. Gupta, and N. K. Jain, Development and characterization of triazine based dendrimers for delivery of antitumor agent. J. Nanosci. Nanotechnol. 10, 8395 (2010).
31. S. A. Jenekhe and X. Linda Chen, Self-assembled aggregates of rodcoil block copolymers and their solubilization and encapsulation of fullerenes. Science 279, 1903 (1998).
32. S. A. Jenekhe and X. Linda Chen, Self-assembly of ordered microporous materials from rod-coil block copolymers. Science 283, 372 (1999).
33. L. F. Zhang and A. Eisenberg, Multiple morphologies of "crewcut" aggregates of polystyrene-b-poly(acrylic acid) block copolymers. Science 268, 1728 (1995).
34. X. W. Wei, C. Gong, M. L. Gou, S. Z. Fu, Q. F. Guo, S. Shi, F. Luo, G. Guo, L. Y. Qiu, and Z. Y. Qian, Biodegradable poly(epsiloncaprolactone)- poly(ethylene glycol) copolymers as drug delivery system. Int. J. Pharm. 381, 1 (2009).
35. Y. J. Wang, C. Wang, S. Z. Fu, Q. Liu, D. Y. Dou, H. Lv, M. Fan, G. Guo, F. Luo, and Z. Y. Qian, Preparation of tacrolimus loaded micelles based on poly(epsilon-caprolactone)-poly(ethylene glycol)-poly(epsilon-caprolactone). Int. J. Pharm. 407, 184 (2011).
36. A. Lamprecht, H. Yamamoto, H. Takeuchi, and Y. Kawashima, Nanoparticles enhance therapeutic efficiency by selectively increased local drug dose in experimental colitis in rats. J. Pharmacol. Exp. Ther. 315, 196 (2005).
37. G. Gaucher, M. H. Dufresne, V. P. Sant, N. Kang, D. Maysinger, and J. C. Leroux, Block copolymer micelles: Preparation, characterization and application in drug delivery. J. Controlled Release 109, 169 (2005).
38. M. L. Gou, X. L. Zheng, K. Men, J. Zhang, B. L. Wang, L. Lv, X. H. Wang, Y. L. Zhao, F. Luo, L. J. Chen, X. Zhao, Y. Q. Wei, and Z. Y. Qian, Self-assembled hydrophobic honokiol loaded MPEG-PCL diblock copolymer micelles. Pharm. Res. 26, 2164 (2009).
39. X. W. Wei, C. Y. Gong, S. Shi, S. Z. Fu, K. Men, S. Zeng, X. L. Zheng, M. L. Gou, L. J. Chen, L. Y. Qiu, and Z. Y. Qian, Self-assembled honokiol-loaded micelles based on poly(epsilon-caprolactone)-poly(ethylene glycol)- poly(epsiloncaprolactone) copolymer. Int. J. Pharm. 369, 170 (2008).
40. C. Y. Gong, S. Shi, X. H. Wang, Y. J. Wang, S. Z. Fu, P. W. Dong, L. J. Chen, X. Zhao, Y. Q. Wei, and Z. Y. Qian, Novel composite drug delivery system for honokiol delivery: Selfassembled poly(ethylene glycol)-poly(β- caprolactone)-poly(ethylene glycol) micelles in thermosensitive poly(ethylene glycol)- poly(β-caprolactone)-poly(ethylene glycol) hydrogel. J. Phys. Chem. B 113, 10183 (2009).
41. R. Riva, S. Schmeits, C. Jérôme, R. Jérôme, and P. Lecomte, Combination of ring-opening polymerization and "click chemistry:" Toward functionalization and grafting of poly(e-caprolactone). Macromolecules 40, 796 (2007).
42. L. Piao, Z. Dai, M. Deng, X. Chen, and X. Jing, Synthesis and characterization of PCL/PEG/PCL triblock copolymers by using calcium catalyst. Polymer 44, 2025 (2003).
43. F. Wang, T. K. Bronich, A. V. Kabanov, R. D. Rauh, and J. Roovers, Synthesis and characterization of star poly(e-caprolactone)-b-poly (ethylene glycol) and poly(l-lactide)-b-poly(ethylene glycol) copolymers: Evaluation as drug delivery carriers. Bioconjugate Chem. 19, 1423 (2008).
44. A. V. Kabanov, I. R. Nazarova, I. V. Astafieva, E. V. Batrakova, V. Y. Alakhov, A. A. Yaroslavov, and V. A. Kabanov, Micelle formation and solubilization of fluorescent probes in poly(oxyethylene-b-oxypropylene-b- oxyethylene) solutions. Macromolecules 28, 2303 (1995).
45. E. Fournier, M. H. Dufresne, D. C. Smith, M. Ranger, and J. C. Leroux, A novel one-step drug-loading procedure for water-soluble amphiphilic nanocarriers. Pharm. Res. 21, 962 (2004).
46. D. L. Teagarden and D. S. Baker, Practical aspects of lyophilization using non-aqueous co-solvent systems. Eur. J. Pharm. Sci. 15, 115 (2002).
47. C. Allen, D. Maysinger, and A. Eisenberg, Nano-engineering block copolymer aggregates for drug delivery. Colloids Surf. B: Biointerfaces 16, 3 (1999).
48. S. B. La, T. Okano, and K. Kataoka, Preparation and characterization of the micelle-forming polymeric drug indomethacin-incorporated poly(ethylene oxide)-poly (-benzyl L-aspartate) block copolymer micelles. J. Pharm. Sci. 85, 85 (1996).
49. P. W. Dong, X. H. Wang, Y. C. Gu, Y. J. Wang, Y. J. Wang, C. Y. Gong, F. Luo, G. Guo, X. Zhao, Y. Q. Wei, and Z. Y. Qian, Selfassembled biodegradable micelles based on star-shaped PCL-b-PEG copolymers for chemotherapeutic drug delivery. Colloids Surf. A 358, 128 (2010).
50. S. Shi, M. Fan, X. H. Wang, C. J. Zhao, Y. J. Wang, F. Luo, X. Zhao, and Z. Y. Qian, Synthesis and characterization of MPEG-PCL-g-PEI and self-assembled nanoparticle uptake in vitro and in vivo. J. Phys. Chem. C 114, 21315 (2010).
51. S. Friedman and R. S. Blumberg, Inflammatory bowel disease. Harrison's Principles of Internal Medicine 15, 1679 (2001).
52. S. C. Truelove and L. J. Witts, Cortisone in ulcerative colitis. Brit. Med. J. 2, 1041 (1955).
53. D. C. Baumgart, J. P. Pintoffl, A. Sturm, B. Wiedenmann, and A. U. Dignass, Tacrolimus is safe and effective in patients with severe steroid-refractory or steroid-dependent inflammatory bowel disease - A long-term follow-up. Am. J. Gastroenterol 101, 1048 (2006).
54. S. Yamamoto, H. Nakase, S. Mikami, S. Inoue, T. Yoshino, Y. Takeda, K. Kasahara, S. Ueno, N. Uza, H. Kitamura, H. Tamaki, M. Matsuura, K. Inui, and T. Chiba, Long-term effect of tacrolimus therapy in patients with refractory ulcerative colitis. Aliment. Pharm. Ther. 28, 589 (2008).